Ident. | Authors (with country if any) | Title |
---|
000588 |
Jamie Morton [Australie] ; Martin K. C. Ng [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Giuseppe Mancia [Italie] ; Neil R. Poulter [Royaume-Uni] ; Michel Marre [France] ; Mark E. Cooper [Australie] ; Sophia Zoungas [Australie] | The Association of High-Density Lipoprotein Cholesterol with Cancer Incidence in Type II Diabetes: A Case of Reverse Causality? |
000855 |
S. Wheelwright [Royaume-Uni] ; A.-S. Darlington [Royaume-Uni] ; D. Fitzsimmons [Royaume-Uni] ; P. Fayers [Royaume-Uni, Norvège] ; J. I. Arraras [Espagne] ; F. Bonnetain [France] ; E. Brain [France] ; A. Bredart [France] ; W.-C. Chie [Taïwan] ; J. Giesinger [Autriche] ; E. Hammerlid [Suède] ; S. J. O'Connor [Royaume-Uni] ; S. Oerlemans [Pays-Bas] ; A. Pallis [Grèce] ; M. Reed [Royaume-Uni] ; N. Singhal [Australie] ; V. Vassiliou [Chypre (pays)] ; T. Young [Royaume-Uni] ; C. Johnson [Royaume-Uni] | International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer |
000A39 |
C. Michel Zwaan [Pays-Bas] ; Carmelo Rizzari [Italie] ; Francoise Mechinaud [Australie] ; Donna L. Lancaster [Royaume-Uni] ; Thomas Lehrnbecher [Allemagne] ; Vincent H. J. Van Der Velden [Pays-Bas] ; B. Berna Beverloo [Pays-Bas] ; Monique L. Den Boer [Pays-Bas] ; Rob Pieters [Pays-Bas] ; Dirk Reinhardt [Allemagne] ; Michael Dworzak [Autriche] ; Julie Rosenberg [États-Unis] ; George Manos [États-Unis] ; Shruti Agrawal [États-Unis] ; Lewis Strauss [États-Unis] ; André Baruchel [France] ; Pamela R. Kearns [Royaume-Uni] | Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia: Results of the CA180-018 Phase I Dose-Escalation Study of the Innovative Therapies for Children With Cancer Consortium |
000B11 |
Guy Fagherazzi [France] ; Alice Vilier [France] ; Beverley Balkau [France, Australie] ; Françoise Clavel-Chapelon [France] ; Dianna J. Magliano [Australie] | Anthropometrics, body shape over 12 years and risk of cancer events in pre- and post-menopausal women |
000B33 |
Julien Peron [France] ; Denis Maillet [France] ; Hui K. Gan [Australie] ; Eric X. Chen [Canada] ; Benoit You [France] | Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review |
001339 |
Hui K. Gan [Australie] ; Benoit You [Canada, France] ; Gregory R. Pond [Canada] ; Eric X. Chen [Canada] | Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer |
001369 |
Laura Senovilla [France] ; Ilio Vitale [France] ; Isabelle Martins [France] ; Maximilien Tailler [France] ; Claire Pailleret [France] ; Mickaël Michaud [France] ; Lorenzo Galluzzi [France] ; Sandy Adjemian [France] ; Oliver Kepp [France] ; Mireia Niso-Santano [France] ; Shensi Shen [France] ; Guillermo Marino [France] ; Alfredo Criollo [France] ; Alice Boileve [France] ; Bastien Job [France] ; Sylvain Ladoire [France] ; François Ghiringhelli [France] ; Antonella Sistigu [France] ; Takahiro Yamazaki [France] ; Santiago Rello-Varona [France] ; Clara Locher [France] ; Vichnou Poirier-Coiame [France] ; Monique Talbot ; Alexander Valent [France] ; Francesco Berardinelli [Italie] ; Antonio Antoccia [Italie] ; Fabiola Ciccosanti [Italie] ; Gian Maria Fimia [Italie] ; Mauro Piacentini [Italie] ; Antonio Fueyo [Espagne] ; Nicole L. Messina [Australie] ; MING LI [Australie] ; Christopher J. Chan [Australie] ; Verena Sigl [Autriche] ; Guillaume Pourcher [France] ; Christoph Ruckenstuhl [Autriche] ; Didac Carmona-Gutierrez [Autriche] ; Vladimir Lazar [France] ; Josef M. Penninger [Autriche] ; Frank Madeo [Autriche] ; Carlos Lopez-Otin [Espagne] ; Mark J. Smyth [Australie] ; Laurence Zitvogel [France] ; Maria Castedo ; Guido Kroemer [France] | An Immunosurveillance Mechanism Controls Cancer Cell Ploidy |
001684 |
Milena Maule [Italie] ; Ghislaine Scelo [France] ; Guido Pastore [Italie] ; Paul Brennan [France] ; Kari Hemminki [Allemagne, Suède] ; Jorgen H. Olsen [Danemark] ; Elizabeth Tracey [Australie] ; Eero Pukkala [Finlande] ; Elisabete Weiderpass [Norvège, Suède, Finlande] ; David H. Brewster [Royaume-Uni] ; Sharon Tamaro [Canada] ; Kee-Seng Chia [Singapour, France] ; Vera Pompe-Kirn [Slovénie] ; Erich V. Kliewer [Canada] ; Jon M. Tonita [Canada] ; Carmen Martos [Espagne] ; Jon G. Jonasson [Islande] ; Franco Merletti [Italie] ; Paolo Boffetta [France, États-Unis] | Second malignancies after childhood noncentral nervous system solid cancer: results from 13 cancer registries |
001993 |
Trina J. Stewart [Australie] ; Mark J. Smyth [Australie] | Improving cancer immunotherapy by targeting tumor-induced immune suppression |
001A34 |
Christophe Le Tourneau [France] ; Albiruni R. A. Razak [Canada] ; Hui K. Gan [Australie] ; Simona Pop [France] ; Véronique Dieras [France] ; Patricia Tresca [France] ; Xavier Paoletti [France] | Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literature |
002340 |
Frederiek F. Van Doormaal [Pays-Bas] ; Alexander T. Cohen [Royaume-Uni] ; Bruce L. Davidson [États-Unis] ; Herve Decousus [France] ; Alexander S. Gallus [Australie] ; Michael Gent [Canada] ; Franco Piovella [Italie] ; Martin H. Prins [Pays-Bas] ; Gary E. Raskob [États-Unis] ; Harry R. Büller [Pays-Bas] | Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial |
002735 |
Frederiek F. Van Doormaal [Pays-Bas] ; Gary E. Raskob [États-Unis] ; Bruce L. Davidson [États-Unis] ; Hervé Decousus [France] ; Alexander Gallus [Australie] ; Anthie W. A. Lensing [Pays-Bas] ; Franco Piovella [Italie] ; Martin H. Prins [Pays-Bas] ; Harry R. Büller [Pays-Bas] | Treatment of venous thromboembolism in patients with cancer : Subgroup analysis of the Matisse clinical trials |
002A61 |
Edward L. Trimble [États-Unis, Canada, France, Argentine, Belgique, Royaume-Uni, Australie, Japon] ; Jeffrey S. Abrams ; Ralph M. Meyer ; Fabien Calvo ; Eduardo Cazap ; James Deye ; Elizabeth Eisenhauer ; Thomas J. Fitzgerald ; Denis Lacombe ; Max Parmar ; Nita Seibel ; Lalitha Shankar ; Ann Marie Swart ; Patrick Therasse ; Bhadrasain Vikram ; Remy Von Frenckell ; Michael Friedlander ; Keiichi Fujiwara ; Richard S. Kaplan ; Francoise Meunier | Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials |
003505 |
Peter Andrews [Royaume-Uni] ; Elie Azoulay [France] ; Massimo Antonelli [Italie] ; Laurent Brochard [France] ; Christian Brun-Buisson [France] ; Daniel De Backer [Belgique] ; Geoffrey Dobb [Australie] ; Jean-Yves Fagon [France] ; Herwig Gerlach [Allemagne] ; Johan Groeneveld [Pays-Bas] ; Duncan Macrae [Royaume-Uni] ; Jordi Mancebo [Espagne] ; Philipp Metnitz [Autriche] ; Stefano Nava [Italie] ; Jerome Pugin [Suisse] ; Michael Pinsky [États-Unis] ; Peter Radermacher [Allemagne] ; Christian Richard [France] | Year in Review in Intensive Care Medicine, 2006. III. Circulation, ethics, cancer, outcome, education, nutrition, and pediatric and neonatal critical care |
003663 |
V. Launay-Vacher [France] ; E. Chatelut [France] ; S. M. Lichtman [États-Unis] ; H. Wildiers [Belgique] ; C. Steer [Australie] ; M. Aapro [Suisse] | Renal insufficiency in elderly cancer patients : International Society of Geriatric oncology clinical practice recommendations |
003830 |
Gary Clifford [France] ; Silvia Franceschi [France] ; Andrew E. Grulich [Australie] ; Marina T. Van Leeuwen [Australie] ; Michael O. Falster [Australie] ; Claire M. Vajdic [Australie] | Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients : a meta-analysis. Commentary |
003882 |
John Stagg [Australie] ; Ricky W. Johnstone [Australie] ; Mark J. Smyth [Australie] | From cancer immunosurveillance to cancer immunotherapy |
003956 |
F. Pein [France] ; R. Pinkerton [Australie] ; P. Berthaud [Suisse] ; K. Pritchard-Jones [États-Unis] ; G. Dick [États-Unis] ; G. Vassal [France] | Dose finding study of oral PSC 833 combined with weekly intravenous etoposide in children with relapsed or refractory solid tumours |
003996 |
Paolo Boffetta [France] ; Bruce Armstrong [Australie] ; Martha Linet [États-Unis] ; Carol Kasten [États-Unis] ; Wendy Cozen [États-Unis] ; Patricia Hartge [États-Unis] | Consortia in cancer epidemiology : Lessons from interlymph |
003D58 |
Martine Van Glabbeke [Belgique] ; Jaap Verweij [Pays-Bas] ; Paolo G. Casali [Italie] ; John Simes [Australie] ; Axel Le Cesne [France] ; Peter Reichardt [Allemagne] ; Rolf Issels [Allemagne] ; Ian R. Judson [Royaume-Uni] ; Allan T. Van Oosterom [Belgique] ; Jean-Yves Blay [France] | Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib : A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG) |
003F42 |
Danielle Monniaux [France] ; Clotilde Huet-Calderwood [France] ; Frédériqüe Le Bellego [Canada] ; Stéphane Fabre [France] ; Philippe Monget [France] ; David A. Calderwood [États-Unis] | Integrins in the ovary |